Professor T. Briggs
Medical Director, Royal National Orthopaedic
"I am excited by the potential of this novel device to prevent
significant adverse events in a high risk, high volume
According to the National Joint Registry over 150,000 lower limb
arthroplasty procedures were carried out throughout the UK in 2008.
Thromboembolic phenomena are a significant and common risk
following these operations. DVT prophylaxis is by medical therapy
and by prevention of blood stasis.
We are keen to examine the effect of the neuromuscular stimulator
to lower the risk of post-operative DVT both directly and
indirectly via increased ambulation.
David Warwick, MD BM FRCS FRCS(Orth)
Reader in Orthopaedic Surgery
Wessex Nuffield Hospital, Southampton, SO53
"The geko™ device offers the potential for effective,
affordable and convenient thromboprophylaxis".
Venous thromboembolism is an important, and largely preventable,
problem in orthopaedic surgery. Mechanical methods are intuitively
attractive as they can reduce the risk without introducing the
alternative risk of bleeding that is associated with chemical
methods. Existing mechanical methods rely on sequential or impulse
compression. These devices are relatively cumbersome and expensive.
Electrical stimulation showed encouraging results very many years
ago and the technology warrants a revisit. The geko™ device offers
the potential for effective, affordable and convenient
Professor Ajay Kakkar
Director of the Thrombosis Research Institute,
"This technology has the potential to provide a
paradigm shift in thrombosis prevention".